404 related articles for article (PubMed ID: 2121369)
41. Structural analysis of the GAP-related domain from neurofibromin and its implications.
Scheffzek K; Ahmadian MR; Wiesmüller L; Kabsch W; Stege P; Schmitz F; Wittinghofer A
EMBO J; 1998 Aug; 17(15):4313-27. PubMed ID: 9687500
[TBL] [Abstract][Full Text] [Related]
42. Direct measurement of the binding of RAS to neurofibromin using a scintillation proximity assay.
Skinner RH; Picardo M; Gane NM; Cook ND; Morgan L; Rowedder J; Lowe PN
Anal Biochem; 1994 Dec; 223(2):259-65. PubMed ID: 7887472
[TBL] [Abstract][Full Text] [Related]
43. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.
Klose A; Ahmadian MR; Schuelke M; Scheffzek K; Hoffmeyer S; Gewies A; Schmitz F; Kaufmann D; Peters H; Wittinghofer A; Nürnberg P
Hum Mol Genet; 1998 Aug; 7(8):1261-8. PubMed ID: 9668168
[TBL] [Abstract][Full Text] [Related]
44. Interaction between the Saccharomyces cerevisiae CDC25 gene product and mammalian ras.
Segal M; Marbach I; Engelberg D; Simchen G; Levitzki A
J Biol Chem; 1992 Nov; 267(32):22747-51. PubMed ID: 1429624
[TBL] [Abstract][Full Text] [Related]
45. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
Hattori S; Maekawa M; Nakamura S
Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
[TBL] [Abstract][Full Text] [Related]
46. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
[TBL] [Abstract][Full Text] [Related]
47. Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1).
Griesser J; Kaufmann D; Eisenbarth I; Bäuerle C; Krone W
Biol Chem Hoppe Seyler; 1995 Feb; 376(2):91-101. PubMed ID: 7794530
[TBL] [Abstract][Full Text] [Related]
48. [Heterogeneity of GTPase-activating proteins for Ras in the regulation of Ras signal transduction pathway].
Hattori S; Baba H
Yakugaku Zasshi; 1996 Jan; 116(1):21-38. PubMed ID: 8699317
[TBL] [Abstract][Full Text] [Related]
49. The RasGAP proteins Ira2 and neurofibromin are negatively regulated by Gpb1 in yeast and ETEA in humans.
Phan VT; Ding VW; Li F; Chalkley RJ; Burlingame A; McCormick F
Mol Cell Biol; 2010 May; 30(9):2264-79. PubMed ID: 20160012
[TBL] [Abstract][Full Text] [Related]
50. Identification of a GTPase-activating protein homolog in Schizosaccharomyces pombe.
Imai Y; Miyake S; Hughes DA; Yamamoto M
Mol Cell Biol; 1991 Jun; 11(6):3088-94. PubMed ID: 2038319
[TBL] [Abstract][Full Text] [Related]
51. Determinants of Ras proteins specifying the sensitivity to yeast Ira2p and human p120-GAP.
Parrini MC; Bernardi A; Parmeggiani A
EMBO J; 1996 Mar; 15(5):1107-11. PubMed ID: 8605880
[TBL] [Abstract][Full Text] [Related]
52. Differential regulation of cellular activities by GTPase-activating protein and NF1.
al-Alawi N; Xu G; White R; Clark R; McCormick F; Feramisco JR
Mol Cell Biol; 1993 Apr; 13(4):2497-503. PubMed ID: 8455625
[TBL] [Abstract][Full Text] [Related]
53. Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis.
Gutmann DH; Boguski M; Marchuk D; Wigler M; Collins FS; Ballester R
Oncogene; 1993 Mar; 8(3):761-9. PubMed ID: 8437860
[TBL] [Abstract][Full Text] [Related]
54. BUD2 encodes a GTPase-activating protein for Bud1/Rsr1 necessary for proper bud-site selection in yeast.
Park HO; Chant J; Herskowitz I
Nature; 1993 Sep; 365(6443):269-74. PubMed ID: 8371782
[TBL] [Abstract][Full Text] [Related]
55. Functional interaction between p21rap1A and components of the budding pathway in Saccharomyces cerevisiae.
McCabe PC; Haubruck H; Polakis P; McCormick F; Innis MA
Mol Cell Biol; 1992 Sep; 12(9):4084-92. PubMed ID: 1508205
[TBL] [Abstract][Full Text] [Related]
56. Interactions between the bud emergence proteins Bem1p and Bem2p and Rho-type GTPases in yeast.
Peterson J; Zheng Y; Bender L; Myers A; Cerione R; Bender A
J Cell Biol; 1994 Dec; 127(5):1395-406. PubMed ID: 7962098
[TBL] [Abstract][Full Text] [Related]
57. Requirement of one functional RAS gene and inability of an oncogenic ras variant to mediate the glucose-induced cyclic AMP signal in the yeast Saccharomyces cerevisiae.
Mbonyi K; Beullens M; Detremerie K; Geerts L; Thevelein JM
Mol Cell Biol; 1988 Aug; 8(8):3051-7. PubMed ID: 2850478
[TBL] [Abstract][Full Text] [Related]
58. Ras-regulated signaling processes in Saccharomyces cerevisiae.
Broach JR
Curr Opin Genet Dev; 1991 Oct; 1(3):370-7. PubMed ID: 1668647
[TBL] [Abstract][Full Text] [Related]
59. Expression of three mammalian cDNAs that interfere with RAS function in Saccharomyces cerevisiae.
Colicelli J; Nicolette C; Birchmeier C; Rodgers L; Riggs M; Wigler M
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2913-7. PubMed ID: 1849280
[TBL] [Abstract][Full Text] [Related]
60. Yeast two-hybrid system to detect protein-protein interactions with Rho GTPases.
Aspenström P; Olson MF
Methods Enzymol; 1995; 256():228-41. PubMed ID: 7476436
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
